✉ info@chemsp.cn☎ +86-18553102138 ☎ 0531-84992235
📞 WhatsApp中文
Home › Product Catalog › Elvitegravir

Elvitegravir

CAS 697761-98-1C23H23ClFNO5MW 447.9

Elvitegravir (CAS 697761-98-1) — formula C23H23ClFNO5, molecular weight 447.9; category pharmaceutical intermediates and APIs.

Product Description

Elvitegravir (CAS 697761-98-1) is a pharmaceutical intermediates and APIs. Its molecular formula C23H23ClFNO5 comprises 23 C, 23 H, 1 Cl, 1 F, 1 N, 5 O atoms. Its molecular weight is about 447.9. Reported physicochemical data: LogP about 5.3. Pharmaceutical intermediates and APIs are critical building blocks for drug synthesis, with strict requirements on purity, impurities and process consistency. Used in API synthesis, formulation and pre-clinical research; supplied with COA and impurity-profile documentation. As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.

Product Overview

CAS Number697761-98-1
Molecular FormulaC23H23ClFNO5
Molecular Weight447.9
LogP5.3
Applicationsformulation and pre-clinical research, supplied with COA and impurity-profile documentation. As a sourcing and distribution partner we can help locate and compare this item across domestic and cross-border channels, with COA and compliance files provided before ordering
CategoryPharmaceutical Intermediates & APIs

Applications

Documented applications: formulation and pre-clinical research, supplied with COA and impurity-profile documentation. As a sourcing and distribution partner we can help locate and compare this item across domestic and cross-border channels, with COA and compliance files provided before ordering.

Technical Profile

What this product is

Elvitegravir is a pharmaceutical intermediate or API compound with CAS registry number 697761-98-1 and molecular formula C23H23ClFNO5 (molecular weight 447.9), belonging to the pharmaceutical intermediates and APIs segment of chemical raw materials.

Identification

CAS number: 697761-98-1

Its molecular formula C23H23ClFNO5 comprises 23 C, 23 H, 1 Cl, 1 F, 1 N, 5 O atoms.

Also known as: Elvitegravir · 埃维特拉韦

Category: pharmaceutical intermediates and APIs

Frequently Asked Questions

What is the CAS number of Elvitegravir?

The CAS registry number of Elvitegravir is 697761-98-1.

What is the molecular formula and molecular weight of Elvitegravir?

Molecular formula C23H23ClFNO5, molecular weight 447.9.

What other names is Elvitegravir known by?

It is also registered under: Elvitegravir, 埃维特拉韦.

What are the documented applications of Elvitegravir?

Recorded applications: formulation and pre-clinical research, supplied with COA and impurity-profile documentation. As a sourcing and distribution partner we can help locate and compare this item across domestic and cross-border channels, with COA and compliance files provided before ordering.

Which category does Elvitegravir belong to?

Category: Pharmaceutical Intermediates & APIs.

Packaging & documentation

Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.

PubChem Public Data

Independent reference data for Elvitegravir (CAS 697761-98-1), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number697761-98-1
PubChem CID5277135
Molecular formulaC23H23ClFNO5
IUPAC name6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid
UNII (FDA)4GDQ854U53

Computed descriptors

Molecular Weight447.9
XLogP35.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass447.1248787
Monoisotopic Mass447.1248787
Topological Polar Surface Area87.1
Heavy Atom Count31

Physicochemical values on record

Solubility<0.3 mcg/mL

Documented uses on record

    Elvitegravir in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) is indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antiviral Agents; Anti-HIV Agents; Anti-Retroviral Agents; HIV Integrase Inhibitors

    Synonyms and trade names

    Elvitegravir; 697761-98-1; GS-9137; JTK-303; Vitekta; GS 9137; JTK 303; elvitegravirum; JTK303; CHEBI:72289; GS9137; 4GDQ854U53; DTXSID101021650; VITEKTA COMPONENT ELVITEGRAVIR; STRIBILD COMPONENT ELVITEGRAVIR; RefChem:58903

    Regulatory listings held on file

    GHS notification summary33.3% (1 / 3)

    GHS hazard classification

    GHS notification summary33.3% (1 / 3)
    Reported hazard statementsH400 (33.3%), H410 (33.3%), H411 (33.3%), H412 (33.3%)

    This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.

    H400 (33.3%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

    What the public record says

    Elvitegravir · CAS 697761-98-1 · C23H23ClFNO5. UNII 4GDQ854U53. Solubility: <0.3 mcg/mL.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@chemsp.cn☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 埃维特拉韦

Shenghe Chemical|ChemSP
鲁ICP备19037000号-2